FI763215A - - Google Patents

Info

Publication number
FI763215A
FI763215A FI763215A FI763215A FI763215A FI 763215 A FI763215 A FI 763215A FI 763215 A FI763215 A FI 763215A FI 763215 A FI763215 A FI 763215A FI 763215 A FI763215 A FI 763215A
Authority
FI
Finland
Application number
FI763215A
Other languages
Finnish (fi)
Inventor
Ulrich Gebert
Josef Musil
Rolf-Ortwin Weber
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI763215A publication Critical patent/FI763215A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI763215A 1975-11-13 1976-11-10 FI763215A (US06262066-20010717-C00315.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
FI763215A true FI763215A (US06262066-20010717-C00315.png) 1977-05-14

Family

ID=5961645

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763215A FI763215A (US06262066-20010717-C00315.png) 1975-11-13 1976-11-10

Country Status (21)

Country Link
US (1) US4152440A (US06262066-20010717-C00315.png)
JP (3) JPS5262278A (US06262066-20010717-C00315.png)
AT (1) AT357155B (US06262066-20010717-C00315.png)
AU (1) AU504009B2 (US06262066-20010717-C00315.png)
BE (1) BE848280A (US06262066-20010717-C00315.png)
CA (1) CA1097350A (US06262066-20010717-C00315.png)
DE (1) DE2550959C3 (US06262066-20010717-C00315.png)
DK (1) DK511376A (US06262066-20010717-C00315.png)
ES (1) ES453276A1 (US06262066-20010717-C00315.png)
FI (1) FI763215A (US06262066-20010717-C00315.png)
FR (1) FR2363328A1 (US06262066-20010717-C00315.png)
GB (1) GB1545939A (US06262066-20010717-C00315.png)
GR (1) GR70648B (US06262066-20010717-C00315.png)
HU (1) HU173879B (US06262066-20010717-C00315.png)
IE (1) IE44184B1 (US06262066-20010717-C00315.png)
IL (1) IL50892A (US06262066-20010717-C00315.png)
LU (1) LU76188A1 (US06262066-20010717-C00315.png)
NL (1) NL7612610A (US06262066-20010717-C00315.png)
NO (1) NO763876L (US06262066-20010717-C00315.png)
SE (1) SE7612685L (US06262066-20010717-C00315.png)
ZA (1) ZA766715B (US06262066-20010717-C00315.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
EP1765789B1 (en) * 2004-06-18 2013-02-27 Novartis AG N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
JP2010515687A (ja) * 2007-01-05 2010-05-13 ノバルティス アーゲー キネシンスピンドルタンパク質阻害剤(eg−5)としてのイミダゾール誘導体
TW200916098A (en) * 2007-06-14 2009-04-16 Teijin Pharma Ltd Agent for lowering uric acid level
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2326631A4 (en) * 2008-08-18 2012-03-21 Univ Yale MODULATORS OF MIF
EP2508511A1 (en) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (US06262066-20010717-C00315.png) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (US06262066-20010717-C00315.png) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB1545939A (en) 1979-05-16
DE2550959A1 (de) 1977-05-26
JPS5531155B2 (US06262066-20010717-C00315.png) 1980-08-15
ZA766715B (en) 1977-10-26
US4152440A (en) 1979-05-01
DK511376A (da) 1977-05-14
AU504009B2 (en) 1979-09-27
NL7612610A (nl) 1977-05-17
IL50892A (en) 1981-02-27
AT357155B (de) 1980-06-25
ATA844476A (de) 1979-11-15
CA1097350A (en) 1981-03-10
FR2363328B1 (US06262066-20010717-C00315.png) 1979-08-31
BE848280A (fr) 1977-05-12
IL50892A0 (en) 1977-01-31
JPS5547677A (en) 1980-04-04
NO763876L (US06262066-20010717-C00315.png) 1977-05-16
AU1952576A (en) 1978-05-18
ES453276A1 (es) 1978-02-01
JPS5262278A (en) 1977-05-23
SE7612685L (sv) 1977-05-14
DE2550959B2 (de) 1980-04-10
IE44184B1 (en) 1981-09-09
DE2550959C3 (de) 1980-12-04
HU173879B (hu) 1979-09-28
IE44184L (en) 1977-05-13
FR2363328A1 (fr) 1978-03-31
JPS54163578A (en) 1979-12-26
LU76188A1 (US06262066-20010717-C00315.png) 1977-06-06
GR70648B (US06262066-20010717-C00315.png) 1982-12-03

Similar Documents

Publication Publication Date Title
FR2363328B1 (US06262066-20010717-C00315.png)
JPS54275B2 (US06262066-20010717-C00315.png)
JPS5550431Y2 (US06262066-20010717-C00315.png)
JPS5531035Y2 (US06262066-20010717-C00315.png)
JPS5629800Y2 (US06262066-20010717-C00315.png)
JPS5534901Y2 (US06262066-20010717-C00315.png)
JPS5330071Y2 (US06262066-20010717-C00315.png)
JPS5310916B2 (US06262066-20010717-C00315.png)
JPS5257443U (US06262066-20010717-C00315.png)
JPS5286960U (US06262066-20010717-C00315.png)
CH597224A5 (US06262066-20010717-C00315.png)
BG21639A1 (US06262066-20010717-C00315.png)
CH594184A5 (US06262066-20010717-C00315.png)
CH592898A5 (US06262066-20010717-C00315.png)
BG22304A1 (US06262066-20010717-C00315.png)
BG22551A1 (US06262066-20010717-C00315.png)
CH592518A5 (US06262066-20010717-C00315.png)
CH591966A5 (US06262066-20010717-C00315.png)
CH597413A5 (US06262066-20010717-C00315.png)
CH597677A5 (US06262066-20010717-C00315.png)
CH594830A5 (US06262066-20010717-C00315.png)
BG22195A1 (US06262066-20010717-C00315.png)
CH598077A5 (US06262066-20010717-C00315.png)
BG23303A1 (US06262066-20010717-C00315.png)
BG24711A1 (US06262066-20010717-C00315.png)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AG